Hedgeye Fourth Turning ETF (HEFT)
Live price chart, market sentiment, and community perspectives for Hedgeye Fourth Turning ETF (AMEX: HEFT).
Live price chart, market sentiment, and community perspectives for Hedgeye Fourth Turning ETF (AMEX: HEFT).
On our desk, evaluating the Hedgeye Fourth Turning ETF (HEFT) comes down to its unique thematic hook anchored by Neil Howe's generational theory. With a gross expense ratio of 0.70% and net assets around $82.5M as of mid-2026, it occupies a distinct niche for macro-driven long-short strategies. However, given its launch date of November 20, 2025, the limited track record makes institutional commitment tentative until it proves its risk-adjusted alpha.
From a risk management standpoint, HEFT's structural requirement to maintain exposure between 150% long and 50% short creates unique volatility dynamics. Our quantitative models show it tracking mid-cap blend characteristics with a 30-day SEC yield of 0.59%. While 24 institutional funds held about $43.6M in Q2 2026, the 9.81% reduction in total fund ownership signals that institutional conviction is still being tested against broader market benchmarks like SPY.
In our quantitative research meetings, we noted that third-party AI scoring systems like Danelfin assign HEFT a 'Hold' (6/10 score), pointing to only a marginal probability advantage of beating benchmarks over a 3-month horizon. Advisory services like Upturn have similarly categorized the fund as a 'Pass' following simulated performance pullbacks. Analysts wanting to allocate should scrutinize how R. Patrick Kent and Neil Howe manage the long-short spread during periods of acute economic upheaval.
Watching the macro community react to HEFT has been fascinating. The integration of Hedgeye’s quantitative macro models with fundamental generational insights appeals directly to retail and institutional followers of Keith McCullough and Neil Howe alike. Even so, historical performance showing a -3.3% historic profit metric in simulated advisory trackers indicates that thematic appeal must be backed by consistent execution through the ongoing Fourth Turning cycle.
Our analysis of Q2 2026 regulatory filings for HEFT highlights a mixed institutional sentiment: 8 funds opened new positions and 5 increased holdings, but 8 reduced and 1 closed out entirely. This turnover demonstrates that while the fund's premise—capitalizing on systemic socio-economic shifts—resonates with macro allocators, the execution and near-term price action between its $24.92 and $28.84 year range require careful monitoring before scaling up.
Explore plasma cleansing, somatic organ swaps, and BCI.